Diabetes Drugs Have High Rate Of Cancer Links: Report

Law360, New York (April 18, 2013, 7:54 PM EDT) -- U.S. Food and Drug Administration data show that certain diabetes drugs made by Merck & Co. Inc., AstraZeneca PLC and others, which are already under investigation by the agency, are 25 times more likely to be linked to pancreatic cancer than other diabetes drugs, a watchdog group said Thursday.

The Institute for Safe Medication Practices examined a year's worth of reports made to the FDA for adverse events related to five Type 2 diabetes drugs, including Januvia, made by Merck; Byetta, made by AstraZeneca and Bristol-Myers...
To view the full article, register now.